- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 958567, 8 pages
Anti-Inflammatory Activity of Bioaccessible Fraction from Eryngium foetidum Leaves
Institute of Nutrition, Mahidol University, Salaya, Nakhon Pathom 73170, Thailand
Received 30 April 2013; Revised 29 July 2013; Accepted 1 August 2013
Academic Editor: Manish K. Chourasia
Copyright © 2013 Suwitcha Dawilai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. Eckmann, H. C. Jung, C. Schürer-Maly, A. Panja, E. Morzycka-Wroblewska, and M. F. Kagnoff, “Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8,” Gastroenterology, vol. 105, no. 6, pp. 1689–1697, 1993.
- K. Yamamoto, R. Kushima, O. Kisaki, Y. Fujiyama, and H. Okabe, “Combined effect of hydrogen peroxide induced oxidative stress and IL-1α on IL-8 production in CaCo-2 cells (a human colon carcinoma cell line) and normal intestinal epithelial cells,” Inflammation, vol. 27, no. 3, pp. 123–128, 2003.
- T. T. Macdonald and G. Monteleone, “Immunity, inflammation, and allergy in the gut,” Science, vol. 307, no. 5717, pp. 1920–1925, 2005.
- B. Sonier, C. Patrick, P. Ajjikuttira, and F. W. Scoot, “Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity,” International Reviews of Immunology, vol. 28, no. 6, pp. 414–445, 2009.
- D. Wang, R. N. DuBois, and A. Richmond, “The role of chemokines in intestinal inflammation and cancer,” Current Opinion in Pharmacology, vol. 9, no. 6, pp. 688–696, 2009.
- R. P. MacDermott, “Chemokines in the inflammatory bowel diseases,” Journal of Clinical Immunology, vol. 19, no. 5, pp. 266–272, 1999.
- K. Ina, K. Kusugami, T. Yamaguchi, et al., “Mucosal interleukin8 is involved in neutrophil migration and binding to extracellular matrix in inflammatory bowel disease,” The American Journal of Gastroenterology, vol. 92, no. 8, pp. 1342–1346, 1997.
- C. Banks, A. Bateman, R. Payne, P. Johnson, and N. Sheron, “Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease,” The Journal of Pathology, vol. 199, no. 1, pp. 28–35, 2003.
- H. C. Reinecker, E. Y. Loh, D. J. Ringler, A. Mehta, J. L. Rombeau, and R. P. MacDermott, “Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa,” Gastroenterology, vol. 108, no. 1, pp. 40–50, 1995.
- H. C. Reinecker and D. K. Podolsky, “Human intestinal epithelial cells express functional cytokine receptors sharing the common γ c chain of the interleukin 2 receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 18, pp. 8353–8357, 1995.
- L. Mazzucchelli, C. Hauser, K. Zgraggen, et al., “Differential in situ expression of the genes encoding the chemokines MCP-1 and rantes in human inflammatory bowel disease,” The Journal of Pathology, vol. 178, no. 2, pp. 201–206, 1996.
- A. Yadav, V. Saini, and S. Arora, “MCP-1: chemoattractant with a role beyond immunity: a review,” Clinica Chimica Acta, vol. 411, no. 21-22, pp. 1570–1579, 2010.
- H. Zhu and Y. Li, “Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence,” Experimental Biology and Medicine, vol. 237, no. 5, pp. 474–480, 2012.
- P. Rutgeerts, B. G. Feagan, G. R. Lichtenstein et al., “Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease,” Gastroenterology, vol. 126, no. 2, pp. 402–413, 2004.
- B. E. Sands, F. H. Anderson, C. N. Bernstein et al., “Infliximab maintenance therapy for fistulizing Crohn's disease,” The New England Journal of Medicine, vol. 350, no. 9, pp. 876–885, 2004.
- S. B. Hanauer and F. Baert, “Medical therapy of inflammatory bowel disease,” Medical Clinics of North America, vol. 78, no. 6, pp. 1413–1426, 1994.
- A. Stallmach, S. Hagel, and T. Bruns, “Adverse effects of biologics used for treating IBD,” Best Practice & Research Clinical Gastroenterology, vol. 24, no. 2, pp. 167–182, 2010.
- J. González-Gallego, M. V. García-Mediavilla, S. Sánchez-Campos, and M. J. Tuñó, “Fruit polyphenols, immunity and inflammation,” The British Journal of Nutrition, vol. 104, supplement 3, pp. S15–S27, 2010.
- F. Biasi, M. Astegiano, M. Maina, G. Leonarduzzi, and G. Poli, “Polyphenol supplementation as a complementary medicinal approach to treating inflammatory bowel disease,” Current Medicinal Chemistry, vol. 18, no. 31, pp. 4851–4865, 2011.
- J. Duke, Duke's Handbook of Medicinal Plants of Latin America, CRC Press, Taylor and Francis, Boca Raton, FL, USA, 2009.
- R. Chhetri, “Trends in ethnodomestication of some wild plants in Meghalaya, Northeast India,” Indian Journal of Traditional Knowledge, vol. 5, no. 3, pp. 342–347, 2006.
- P. R. C. Prasad, C. S. Reddy, S. H. Raza, and C. B. S. Dutt, “Folklore medicinal plants of North Andaman Islands, India,” Fitoterapia, vol. 79, no. 6, pp. 458–464, 2008.
- The National Bureau of Agricultural Commodity and Food Standards, Ministry of Agriculture and Cooperatives, Thailand, “The amount of food consumption at 95 percentile per capita and eater only,” in Food Consumption Data of Thailand, p. 173, The Agricultural Co-Operative Federation of Thailand, Bangkok, Thailand, 2006.
- V. Lo, N. An, and N. Toanh, “Study of essential oil of Eryngium foetidum L.,” Tap Chi Duoc, vol. 6, pp. 19–20, 1991.
- J. H. A. Paul, C. E. Seaforth, and T. Tikasingh, “Eryngium foetidum L.: a review,” Fitoterapia, vol. 82, no. 3, pp. 302–308, 2011.
- C. Mekhora, C. Muangnoi, P. Chingsuwanrote, et al., “Eryngium foetidum suppresses inflammatory mediators produced by macrophages,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 2, pp. 653–664, 2012.
- M. D. Garcia, M. T. Saenz, M. A. Gomez, and M. A. Fernandez, “Topical antiinflammatory activity of phytosterols isolated from Eryngium foetidum on chronic and acute inflammation models,” Phytotherapy Research, vol. 13, no. 1, pp. 78–80, 1999.
- M. Saenz, M. Fernandez, and M. Garcia, “Antiinflammatory and analgesic properties from leaves of Eryngium foetidum L., (Apiaceae),” Phytotherapy Research, vol. 11, pp. 380–383, 1997.
- M. Shimizu, “Interaction between food substances and the intestinal epithelium,” Bioscience, Biotechnology and Biochemistry, vol. 74, no. 2, pp. 232–241, 2010.
- D. A. Garrett, M. L. Failla, and R. J. Sarama, “Development of an in vitro digestion method to assess carotenoid bioavailability from meals,” Journal of Agricultural and Food Chemistry, vol. 47, no. 10, pp. 4301–4309, 1999.
- M. G. Ferruzzi, J. L. Lumpkin, S. J. Schwartz, and M. Failla, “Digestive stability, micellarization, and uptake of β-carotene isomers by Caco-2 human intestinal cells,” Journal of Agricultural and Food Chemistry, vol. 54, no. 7, pp. 2780–2785, 2006.
- A. I. Olives Barba, M. Cámara Hurtado, M. C. Sánchez Mata, V. Fernández Ruiz, and M. López Sáenz de Tejada, “Application of a UV-vis detection-HPLC method for a rapid determination of lycopene and β-carotene in vegetables,” Food Chemistry, vol. 95, no. 2, pp. 328–336, 2006.
- S. Tuntipopipat, C. Muangnoi, P. Chingsuwanrote et al., “Anti-inflammatory activities of red curry paste extract on lipopolysaccharide-activated murine macrophage cell line,” Nutrition, vol. 27, no. 4, pp. 479–487, 2011.
- H. M. Merken and G. R. Beecher, “Liquid chromatographic method for the separation and quantification of prominent flavonoid aglycones,” Journal of Chromatography A, vol. 897, no. 1-2, pp. 177–184, 2000.
- V. Vichai and K. Kirtikara, “Sulforhodamine B colorimetric assay for cytotoxicity screening,” Nature Protocols, vol. 1, no. 3, pp. 1112–1116, 2006.
- Y. Kim, J. H. Seo, and H. Kim, “β-carotene and lutein inhibit hydrogen peroxide-induced activation of NF-κB and IL-8 expression in gastric epithelial AGS cells,” Journal of Nutritional Science and Vitaminology, vol. 57, no. 3, pp. 216–223, 2011.
- A. Lavy, Y. Naveh, R. Coleman, S. Mokady, and M. J. Werman, “Dietary dunaliella bardawil, a β-carotene-rich alga, protects against acetic acid-induced small bowel inflammation in rats,” Inflammatory Bowel Diseases, vol. 9, no. 6, pp. 372–379, 2003.
- M. Hernández-Ortega, A. Ortiz-Moreno, M. D. Hernández-Navarro, et al., “Antioxidant, antinociceptive, and anti-inflammatory effects of carotenoids extracted from dried pepper (Capsicum annuum L.),” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 524019, 10 pages, 2012.
- Z. Zhao, H. S. Shin, H. Satsu, M. Totsuka, and M. Shimizu, “5-caffeoylquinic acid and caffeic acid down-regulate the oxidative stress- and TNF-α-induced secretion of interleukin-8 from Caco-2 cells,” Journal of Agricultural and Food Chemistry, vol. 56, no. 10, pp. 3863–3868, 2008.
- Z. Ye, Z. Liu, A. Henderson et al., “Increased CYP4B1 mRNA is associated with the inhibition of dextran sulfate sodium-induced colitis by caffeic acid in mice,” Experimental Biology and Medicine, vol. 234, no. 6, pp. 606–616, 2009.
- C. Wall, R. Lim, M. Poljak, et al., “Dietary flavonoids as therapeutics for preterm birth: luteolin and kaempferol suppress inflammation in human gestational tissues in vitro,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 485201, 10 pages, 2013.
- M. Hämäläinen, R. Nieminen, P. Vuorela, M. Heinonen, and E. Moilanen, “Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages,” Mediators of Inflammation, vol. 2007, Article ID 45673, 10 pages, 2007.
- M. Y. Park, G. E. Ji, and M. K. Sung, “Dietary kaempferol suppresses inflammation of dextran sulfate sodium-induced colitis in mice,” Digestive Diseases and Sciences, vol. 57, no. 2, pp. 355–363, 2012.
- Y. Sato, S. Itagaki, T. Kurokawa et al., “In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid,” International Journal of Pharmaceutics, vol. 403, no. 1-2, pp. 136–138, 2011.
- P.-C. Chao, C.-C. Hsu, and M.-C. Yin, “Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice,” Nutrition & Metabolism, vol. 6, article 33, 2009.
- P. Nirmala and M. Ramanathan, “Effect of kaempferol on lipid peroxidation and antioxidant status in 1,2-dimethyl hydrazine induced colorectal carcinoma in rats,” European Journal of Pharmacology, vol. 654, no. 1, pp. 75–79, 2011.